跳至主要内容
临床试验/NCT06217016
NCT06217016撤回不适用

Effect of Intermittent Urethral Catheter Clamping Combined With Active Urination Training (ICCAUT) Strategy on Postoperative Re-catheterization Secondary to Urinary Retention After Radical Rectal Cancer Surgery (ICCAUT-2)

The First Hospital of Jilin University1 个研究点 分布在 1 个国家目标入组 1,686 人开始时间: 2024年3月21日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
1,686
试验地点
1
主要终点
secondary catheterization owing to urinary retention

研究概览

简要总结

The objective of this trial is to investigate the effect of bladder training on the incidence of re-catheterization after proctectomy. In this study, the bladder training include intermittent urethral catheter clamping combined with active urination training, which we called ICCAUT strategy. This prospective, single-center, randomized controlled trial will enroll patients with rectal cancer who will be randomized in a 1:1 ratio to the ICCAUT group or the free-drainage group. In the ICCAUT group, patients will undergo intermittent clamping of the urinary catheter before its removal. Each time the catheter is released, we will encourage the patients to actively initiate urination to facilitate complete bladder emptying. While patients in the free-drainage group will not undergo any specific training. The urinary catheter will be removed on the second postoperative day for both groups. The primary endpoint is the incidence of re-catheterization due to urinary retention. Secondary endpoints include urinary tract infection (UTI), time of first urination after catheter removal, residual urine volume after the first urination, postoperative morbidity and mortality within 30 days, as well as urinary function within 30 postoperative days.

详细描述

Urinary catheter placement is a standard procedure before proctectomy. However, the necessity of bladder training prior to catheter removal remains uncertain. The objective of this trial is to investigate the effect of bladder training on the incidence of re-catheterization after proctectomy. In this study, the bladder training include intermittent urethral catheter clamping combined with active urination training, which we called ICCAUT strategy. This prospective, single-center, randomized controlled trial will enroll patients with rectal cancer who will be randomized in a 1:1 ratio to the ICCAUT group or the free-drainage group. In the ICCAUT group, patients will undergo intermittent clamping of the urinary catheter before its removal. Each time the catheter is released, we will encourage the patients to actively initiate urination to facilitate complete bladder emptying. While patients in the free-drainage group will not undergo any specific training. The urinary catheter will be removed on the second postoperative day for both groups. The primary endpoint is the incidence of re-catheterization due to urinary retention. Secondary endpoints include urinary tract infection (UTI), time of first urination after catheter removal, residual urine volume after the first urination, postoperative morbidity and mortality within 30 days, as well as urinary function within 30 postoperative days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Outcomes Assessor)

盲法说明

The patients and bedside nurses cannot be blinded, but the attending physicians and the medical ultrasound doctor will be blinded. The medical team will ensure that the patients and bedside nurses keep the group assignment confidential from the attending physicians and the medical ultrasound doctor. Unblinding will occur when the patient is discharged, and any instances of premature unblinding will be recorded. Additionally, the data analysts involved in this study will be blinded.

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with a confirmed preoperative diagnosis of rectal cancer.
  • Patients with tumors located below the rectosigmoid junction, as determined by preoperative computed tomography (CT) or rectal magnetic resonance imaging (MRI).
  • Patients undergoing laparoscopic or robotic-assisted total mesorectal excision (TME) for rectal cancer.

排除标准

  • History of abdominal surgery involving the rectum, sigmoid colon, left hemicolectomy, bladder resection or partial resection, prostate surgery, or hysterectomy.
  • History of urethral injury, cranial surgery, spinal surgery, stroke with limb dysfunction, or Parkinson's disease.
  • Inability to urinate through the urethra preoperatively due to various reasons (e.g., ureteral puncture or ureterostomy).
  • Presence of urinary tract infection preoperatively.
  • Previously diagnosed with bladder overactivity syndrome, urinary retention or voiding dysfunction, or diabetic bladder disease.
  • Concomitant resection of other pelvic organs was performed during surgery, including the bladder, prostate, uterus, cervix, and vagina, except for simple adnexal resection.
  • Lateral lymph node dissection for rectal cancer.
  • Injury to the ureter, bladder, or urethra during the perioperative period.
  • Preoperative renal dysfunction (serum creatinine level >133 μmol/L).
  • Emergency surgery.
  • Male patients with preoperative benign prostatic hyperplasia receiving medication treatment.
  • Patients with a ureteral stent or ureteral stricture, or bilateral hydronephrosis.
  • Conversion to open surgery.
  • Withdrawal Criteria:
  • After randomization, patients will be withdrawn from the trial if the following situations occur:
  • Inability to remove the urinary catheter within 5 days postoperatively due to various reasons (e.g., impaired consciousness, transfer to the intensive care unit (ICU), Sequential Organ Failure Assessment (SOFA) score ≥2, etc.).
  • Secondary catheterization was performed after catheter removal for reasons other than urinary retention (e.g., secondary surgery, shock, rectal bladder leakage, ureteral leakage, or urethral injury).
  • Patient requests to withdraw from the study at any time during the entire study process.
  • Selective α1-adrenergic receptor blocker is used during the first catheterization of the patient due to medical necessity.

结局指标

主要结局

secondary catheterization owing to urinary retention

时间窗: within 7 days after the first time of urethral catheter removal

The primary endpoint of this study is the rate of secondary catheterization owing to urinary retention until discharge. Secondary catheterization can be performed by urethral catheter insertion or suprapubic puncture. The decision to perform secondary catheterization is based on the specific criteria determined by the clinician.

次要结局

  • Urinary tract infections(within 1 days after the first time of urethral catheter removal)
  • The time to first voiding after catheter removal(within 1 days after the first time of urethral catheter removal)
  • The residual urine volume after the first voiding(within 1 days after the first time of urethral catheter removal)
  • Graded assessment of catheter-related bladder discomfort (CRBD)(within 1 days after the first time of urethral catheter removal)
  • Voiding function(on the second day after the first time of urethral catheter removal, and at the 30th day after surgery)
  • Postoperative complications(within 30 days after the operation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuchen Guo, Ph.D.

Prof.

The First Hospital of Jilin University

研究点 (1)

Loading locations...

相似试验

Effect of ICCAUT Strategy on Postoperative Urinary... | 临床试验